167 related articles for article (PubMed ID: 15838170)
1. Rectal cancer: the role of radiotherapy.
Lidder PG; Hosie KB
Dig Surg; 2005; 22(1-2):41-8; discussion 49. PubMed ID: 15838170
[TBL] [Abstract][Full Text] [Related]
2. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
3. Is local excision and chemoradiation an acceptable alternative in the treatment of early rectal cancer?
Spiliotis JD; Datsis AC
J BUON; 2007; 12(1):23-7. PubMed ID: 17436397
[TBL] [Abstract][Full Text] [Related]
4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
5. Saving the sphincter in rectal cancer: are we prepared to change practice?
Wallace MH; Glynne-Jones R
Colorectal Dis; 2007 May; 9(4):302-8; discussion 308-9. PubMed ID: 17432980
[TBL] [Abstract][Full Text] [Related]
6. The multidisciplinary management of rectal cancer.
Meredith KL; Hoffe SE; Shibata D
Surg Clin North Am; 2009 Feb; 89(1):177-215, ix-x. PubMed ID: 19186236
[TBL] [Abstract][Full Text] [Related]
7. Is radiotherapy for rectal cancer indicated if surgery is optimized?
Edwards DP; Mortensen NJ
Eur J Surg Oncol; 2001 Aug; 27(5):442-5. PubMed ID: 11504512
[No Abstract] [Full Text] [Related]
8. [Rectal carcinoma. Optimizing treatment by neoadjuvant and adjuvant therapy?].
Fasolini F
Zentralbl Chir; 1999; 124(5):441-5. PubMed ID: 10420532
[TBL] [Abstract][Full Text] [Related]
9. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy alone for early-stage rectal cancer: an evolving paradigm?
Hawkes EA; Cunningham D; Tait D; Brown G; Chau I
Semin Radiat Oncol; 2011 Jul; 21(3):196-202. PubMed ID: 21645864
[TBL] [Abstract][Full Text] [Related]
11. Surgery for local recurrence of rectal cancer.
Heriot AG; Tekkis PP; Darzi A; Mackay J
Colorectal Dis; 2006 Nov; 8(9):733-47. PubMed ID: 17032318
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy is valuable in the treatment of rectal cancer despite total mesorectal excision.
Colquhoun P; Wexner SD; Cohen A
J Surg Oncol; 2003 Jul; 83(3):133-9. PubMed ID: 12827680
[No Abstract] [Full Text] [Related]
13. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
[TBL] [Abstract][Full Text] [Related]
14. [Rectal carcinoma--oncologically adequate resection].
Simon D
Praxis (Bern 1994); 2001 Apr; 90(14):575-80. PubMed ID: 11320884
[TBL] [Abstract][Full Text] [Related]
15. Is postoperative radiotherapy useful for the rectal carcinoma in the era of total mesorectal excision?
Suh KW; Kim BW; Chun M; Lim HY
Hepatogastroenterology; 2002; 49(44):399-403. PubMed ID: 11995460
[TBL] [Abstract][Full Text] [Related]
16. [Laparoscopic surgery of rectal carcinoma. Radical oncology and late results].
Bärlehner E; Decker T; Anders S; Heukrodt B
Zentralbl Chir; 2001 Apr; 126(4):302-6. PubMed ID: 11370393
[TBL] [Abstract][Full Text] [Related]
17. Total mesorectal excision with autonomic nerve preservation: a new foundation for the evaluation of multi-disciplinary adjuvant therapy in the management of rectal cancers.
Kafka NJ; Enker WE
Ann Chir; 1999; 53(10):996-1002. PubMed ID: 10670148
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiation therapy in resectable rectal cancer: should local recurrence rates affect the decision?
Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K
Am Surg; 1997 Jul; 63(7):579-84; discussion 584-5. PubMed ID: 9202530
[TBL] [Abstract][Full Text] [Related]
19. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
